参天製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/02/21 | 1,719 | 1,741 | 1,707 | 1,723 | -13 | -0.7% | 1,496,000 |
2018/02/20 | 1,743 | 1,755 | 1,726 | 1,736 | -23 | -1.3% | 837,000 |
2018/02/19 | 1,724 | 1,760 | 1,701 | 1,759 | +60 | +3.5% | 942,600 |
2018/02/16 | 1,678 | 1,718 | 1,676 | 1,699 | +38 | +2.3% | 902,200 |
2018/02/15 | 1,654 | 1,680 | 1,617 | 1,661 | +11 | +0.7% | 1,350,800 |
2018/02/14 | 1,615 | 1,656 | 1,615 | 1,650 | +37 | +2.3% | 1,771,100 |
2018/02/13 | 1,655 | 1,660 | 1,608 | 1,613 | -23 | -1.4% | 1,133,800 |
2018/02/09 | 1,625 | 1,641 | 1,618 | 1,636 | -38 | -2.3% | 1,569,200 |
2018/02/08 | 1,685 | 1,692 | 1,664 | 1,674 | -12 | -0.7% | 1,517,800 |
2018/02/07 | 1,773 | 1,774 | 1,685 | 1,686 | +4 | +0.2% | 2,408,400 |
2018/02/06 | 1,716 | 1,728 | 1,646 | 1,682 | -98 | -5.5% | 2,057,300 |
2018/02/05 | 1,786 | 1,810 | 1,778 | 1,780 | -44 | -2.4% | 1,031,300 |
2018/02/02 | 1,812 | 1,830 | 1,791 | 1,824 | -4 | -0.2% | 797,100 |
2018/02/01 | 1,788 | 1,829 | 1,777 | 1,828 | +47 | +2.6% | 1,119,800 |
2018/01/31 | 1,800 | 1,815 | 1,780 | 1,781 | -43 | -2.4% | 1,168,200 |
2018/01/30 | 1,842 | 1,855 | 1,822 | 1,824 | -29 | -1.6% | 882,800 |
2018/01/29 | 1,872 | 1,880 | 1,852 | 1,853 | -5 | -0.3% | 691,000 |
2018/01/26 | 1,835 | 1,884 | 1,835 | 1,858 | +16 | +0.9% | 1,015,500 |
2018/01/25 | 1,834 | 1,863 | 1,832 | 1,842 | +8 | +0.4% | 1,319,000 |
2018/01/24 | 1,818 | 1,838 | 1,807 | 1,834 | +6 | +0.3% | 952,900 |
2018/01/23 | 1,800 | 1,832 | 1,791 | 1,828 | +53 | +3% | 1,215,300 |
2018/01/22 | 1,754 | 1,779 | 1,736 | 1,775 | +23 | +1.3% | 809,300 |
2018/01/19 | 1,755 | 1,768 | 1,745 | 1,752 | +1 | +0.1% | 790,800 |
2018/01/18 | 1,792 | 1,794 | 1,750 | 1,751 | -45 | -2.5% | 1,469,600 |
2018/01/17 | 1,782 | 1,796 | 1,767 | 1,796 | -8 | -0.4% | 1,002,900 |
2018/01/16 | 1,798 | 1,807 | 1,792 | 1,804 | +3 | +0.2% | 603,700 |
2018/01/15 | 1,793 | 1,802 | 1,781 | 1,801 | +23 | +1.3% | 457,000 |
2018/01/12 | 1,799 | 1,801 | 1,773 | 1,778 | -32 | -1.8% | 1,230,000 |
2018/01/11 | 1,833 | 1,856 | 1,791 | 1,810 | -33 | -1.8% | 1,686,700 |
2018/01/10 | 1,815 | 1,848 | 1,806 | 1,843 | +24 | +1.3% | 1,230,000 |
2018/01/09 | 1,826 | 1,834 | 1,812 | 1,819 | +9 | +0.5% | 1,300,500 |
2018/01/05 | 1,801 | 1,815 | 1,790 | 1,810 | +12 | +0.7% | 871,400 |
2018/01/04 | 1,789 | 1,798 | 1,772 | 1,798 | +27 | +1.5% | 1,614,900 |
2017/12/29 | 1,772 | 1,787 | 1,761 | 1,771 | +2 | +0.1% | 864,100 |
2017/12/28 | 1,742 | 1,773 | 1,742 | 1,769 | +33 | +1.9% | 1,506,300 |
2017/12/27 | 1,749 | 1,756 | 1,734 | 1,736 | -12 | -0.7% | 626,000 |
2017/12/26 | 1,748 | 1,762 | 1,740 | 1,748 | +1 | +0.1% | 1,135,700 |
2017/12/25 | 1,756 | 1,775 | 1,731 | 1,747 | +13 | +0.7% | 1,091,600 |
2017/12/22 | 1,697 | 1,736 | 1,630 | 1,734 | -151 | -8% | 5,664,100 |
2017/12/21 | 1,880 | 1,890 | 1,872 | 1,885 | -8 | -0.4% | 824,200 |
2017/12/20 | 1,902 | 1,906 | 1,889 | 1,893 | -23 | -1.2% | 710,500 |
2017/12/19 | 1,924 | 1,941 | 1,916 | 1,916 | -21 | -1.1% | 910,600 |
2017/12/18 | 1,914 | 1,946 | 1,907 | 1,937 | +29 | +1.5% | 851,300 |
2017/12/15 | 1,913 | 1,924 | 1,901 | 1,908 | -18 | -0.9% | 1,416,700 |
2017/12/14 | 1,935 | 1,941 | 1,903 | 1,926 | +11 | +0.6% | 975,800 |
2017/12/13 | 1,902 | 1,927 | 1,900 | 1,915 | +11 | +0.6% | 1,312,400 |
2017/12/12 | 1,889 | 1,910 | 1,883 | 1,904 | +9 | +0.5% | 1,519,500 |
2017/12/11 | 1,850 | 1,898 | 1,846 | 1,895 | +60 | +3.3% | 1,378,600 |
2017/12/08 | 1,800 | 1,844 | 1,800 | 1,835 | +44 | +2.5% | 2,258,200 |
2017/12/07 | 1,766 | 1,799 | 1,765 | 1,791 | +29 | +1.6% | 1,082,900 |
1651~
1700
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「参天薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
参天薬 | 167,000円 | 0.0% | +50.6% | 2.04% | 17.79倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
ロート | 280,800円 | +18.2% | +4.2% | 1.18% | 19.90倍 | 2.54倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
ツムラ | 485,800円 | +22.6% | +68.1% | 2.80% | 12.94倍 | 1.25倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 427,700円 | +7.3% | -3.8% | 2.10% | 19.85倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
市場注目の銘柄
チャート関連のコラム